Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease
- PMID: 28902142
- PMCID: PMC5618614
- DOI: 10.3390/ijms18091965
Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease
Abstract
Brain capillary endothelial cells form the blood-brain barrier (BBB), which is covered with basement membranes and is also surrounded by pericytes and astrocyte end-feet in the neurovascular unit. The BBB tightly regulates the molecular exchange between the blood flow and brain parenchyma, thereby regulating the homeostasis of the central nervous system (CNS). Thus, dysfunction of the BBB is likely involved in the pathogenesis of several neurological diseases, including Alzheimer's disease (AD). While amyloid-β (Aβ) deposition and neurofibrillary tangle formation in the brain are central pathological hallmarks in AD, cerebrovascular lesions and BBB alteration have also been shown to frequently coexist. Although further clinical studies should clarify whether BBB disruption is a specific feature of AD pathogenesis, increasing evidence indicates that each component of the neurovascular unit is significantly affected in the presence of AD-related pathologies in animal models and human patients. Conversely, since some portions of Aβ are eliminated along the neurovascular unit and across the BBB, disturbing the pathways may result in exacerbated Aβ accumulation in the brain. Thus, current evidence suggests that BBB dysfunction may causatively and consequently contribute to AD pathogenesis, forming a vicious cycle between brain Aβ accumulation and neurovascular unit impairments during disease progression.
Keywords: amyloid-β; astrocytes; basement membrane; cerebral amyloid angiopathy; endothelial cells; neurovascular unit; pericytes; tight junctions.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.Acta Neuropathol. 2009 Jul;118(1):103-13. doi: 10.1007/s00401-009-0522-3. Epub 2009 Mar 25. Acta Neuropathol. 2009. PMID: 19319544 Free PMC article. Review.
-
Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.Neuropathol Appl Neurobiol. 2022 Apr;48(3):e12782. doi: 10.1111/nan.12782. Epub 2022 Feb 2. Neuropathol Appl Neurobiol. 2022. PMID: 34823269 Review.
-
Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.J Alzheimers Dis. 2019;72(4):1019-1039. doi: 10.3233/JAD-190357. J Alzheimers Dis. 2019. PMID: 31306129 Free PMC article. Review.
-
Interactions between Beta-Amyloid and Pericytes in Alzheimer's Disease.Front Biosci (Landmark Ed). 2024 Apr 2;29(4):136. doi: 10.31083/j.fbl2904136. Front Biosci (Landmark Ed). 2024. PMID: 38682184 Review.
-
In vitro discrimination of the role of LRP1 at the BBB cellular level: focus on brain capillary endothelial cells and brain pericytes.Brain Res. 2015 Jan 12;1594:15-26. doi: 10.1016/j.brainres.2014.10.047. Epub 2014 Oct 31. Brain Res. 2015. PMID: 25451130
Cited by
-
MicroRNAs in central nervous system diseases: A prospective role in regulating blood-brain barrier integrity.Exp Neurol. 2020 Jan;323:113094. doi: 10.1016/j.expneurol.2019.113094. Epub 2019 Oct 30. Exp Neurol. 2020. PMID: 31676317 Free PMC article. Review.
-
Evidence of beta amyloid independent small vessel disease in familial Alzheimer's disease.Brain Pathol. 2022 Nov;32(6):e13097. doi: 10.1111/bpa.13097. Epub 2022 Jun 13. Brain Pathol. 2022. PMID: 35695802 Free PMC article.
-
Cooperation between neurovascular dysfunction and Aβ in Alzheimer's disease.Front Mol Neurosci. 2023 Aug 16;16:1227493. doi: 10.3389/fnmol.2023.1227493. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37654789 Free PMC article. Review.
-
Mechanisms of Short-Chain Fatty Acids Derived from Gut Microbiota in Alzheimer's Disease.Aging Dis. 2022 Jul 11;13(4):1252-1266. doi: 10.14336/AD.2021.1215. eCollection 2022 Jul 11. Aging Dis. 2022. PMID: 35855330 Free PMC article. Review.
-
Computational model of brain endothelial cell signaling pathways predicts therapeutic targets for cerebral pathologies.J Mol Cell Cardiol. 2022 Mar;164:17-28. doi: 10.1016/j.yjmcc.2021.11.005. Epub 2021 Nov 16. J Mol Cell Cardiol. 2022. PMID: 34798125 Free PMC article.
References
-
- Cines D.B., Pollak E.S., Buck C.A., Loscalzo J., Zimmerman G.A., McEver R.P., Pober J.S., Wick T.M., Konkle B.A., Schwartz B.S., et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 1998;91:3527–3561. - PubMed
-
- Pittman R.N. Colloquium Series on Integrated Systems Physiology: From Molecule to Function. Biota Publishing; Princeton, NJ, USA: 2011. Regulation of Tissue Oxygenation.
-
- Abbas A.K., Lichtman A.H., Pillai S. Cellular and Molecular Immunology. 8th ed. Elsevier Health Sciences; Amsterdam, The Netherlands: 2014. 535p
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
